Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (302)

ClinicalTrials.gov ID: NCT03168334

Public ClinicalTrials.gov record NCT03168334. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 10:59 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2 Arm, Parallel Group Study Comparing the Safety and Efficacy of IDP-123 Lotion and IDP-123 Vehicle Lotion in the Treatment of Acne Vulgaris

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multi-center, randomized, double-blind, vehicle-controlled, 12-week study designed to assess the safety, efficacy, and tolerability of IDP-123 Lotion in comparison with IDP-123 Vehicle Lotion.

Study identification

NCT ID
NCT03168334
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bausch Health Americas, Inc.
Industry
Enrollment
801 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
9 Years to 99 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 11, 2017 (Actual)
Primary completion
Jul 24, 2018 (Actual)
Completion
Jul 24, 2018 (Actual)
Last update posted
Apr 1, 2021

2017 – 2018

United States locations

U.S. sites
41
U.S. states
21
U.S. cities
39
Facility City State ZIP Site status
Valeant Site 41 Mobile Alabama 36608 —
Valeant Site 22 Rogers Arkansas 72758 —
Valeant Site 34 Carlsbad California 92008 —
Valeant Site 12 Fremont California 94538 —
Valeant Site 06 San Diego California 92123 —
Valeant Site 13 San Diego California 92123 —
Valeant Site 31 San Diego California 92123 —
Valeant Site 36 Santa Ana California 92701 —
Valeant Site 25 Denver Colorado 80220 —
Valeant Site 05 Boynton Beach Florida 33437 —
Valeant Site 29 Clearwater Florida 33761 —
Valeant Site 38 Jupiter Florida 33458 —
Valeant Site 02 Miami Florida 33144 —
Valeant Site 26 West Palm Beach Florida 33406 —
Valeant Site 44 Snellville Georgia 30078 —
Valeant Site 32 Louisville Kentucky 40241 —
Valeant Site 19 Rockville Maryland 20850 —
Valeant Site 08 Bay City Michigan 48706 —
Valeant Site 30 Clarkston Michigan 48346 —
Valeant Site 37 Clinton Township Michigan 48038 —
Valeant Site 20 Fort Gratiot Michigan 48059 —
Valeant Site 24 Fridley Minnesota 55432 —
Valeant Site 03 Morristown New Jersey 07960 —
Valeant Site 42 Albuquerque New Mexico 87106 —
Valeant Site 10 New York New York 10155 —
Valeant Site 43 Rochester New York 14623 —
Valeant Site 33 Stony Brook New York 11790 —
Valeant Site 11 Oklahoma City Oklahoma 73112 —
Valeant Site 28 Broomall Pennsylvania 19008 —
Valeant Site 16 Warwick Rhode Island 02886 —
Valeant Site 18 Knoxville Tennessee 37922 —
Valeant Site 14 Murfreesboro Tennessee 37130 —
Valeant Site 23 College Station Texas 77845 —
Valeant Site 07 Dallas Texas 75234 —
Valeant Site 27 Pflugerville Texas 78660 —
Valeant Site 04 San Antonio Texas 78218 —
Valeant Site 39 Sugar Land Texas 77479 —
Valeant Site 09 Layton Utah 84041 —
Valeant Site 15 West Jordan Utah 84088 —
Valeant Site 21 Charlottesville Virginia 22911 —
Valeant Site 35 Walla Walla Washington 99362 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03168334, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 1, 2021 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03168334 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →